Activin a is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes
Conclusions:
Circulating activin A levels are associated with impaired myocardial glucose metabolism and high LVMV-ratio in patients with uncomplicated T2D, reflecting a potential detrimental role in early human diabetic cardiomyopathy.Trial registration numberCurrent Controlled Trials SRCTN53177482
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Weena ChenSabrina GreulichRutger van der MeerLuuk RijzewijkHildo LambAlbert de RoosJohannes SmitJohannes RomijnJohannes RuigeAdriaan LammertsmaMark LubberinkMichaela DiamantD Ouwens Source Type: research
More News: Actos | Cardiology | Cardiomyopathy | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Heart | Insulin | Metformin | MRI Scan | PET Scan | Study